Published in Bull World Health Organ on January 01, 1959
The concentration of sympathin in different parts of the central nervous system under normal conditions and after the administration of drugs. J Physiol (1954) 8.94
Injections of drugs into the lateral ventricle of the cat. J Physiol (1954) 7.92
Pharmacological effects produced by intracerebral injection of drugs in the conscious mouse. Br J Pharmacol Chemother (1957) 6.28
[Pharmacodynamic properties of 3-chloro-10-(3-dimethylaminopropyl)-phenothiazine hydrochloride (R.P. 4560); experimental study of a new substance used in potentialized anesthesia and in artificial hibernation]. Arch Int Pharmacodyn Ther (1953) 5.81
Physiology and pharmacology of vomiting. Pharmacol Rev (1953) 5.03
Amine oxidase and amine metabolism. Pharmacol Rev (1952) 4.95
Noradrenaline in artery walls and its dispersal by reserpine. Br Med J (1958) 4.70
Depression by reserpine of the noradrenaline concentration in the hypothalamus of the cat. J Neurochem (1956) 3.54
Hydrazine derivatives of isonicotinic acid (rimifon marsilid) in the treatment of active progressive caseous-pneumonic tuberculosis; a preliminary report. Am Rev Tuberc (1952) 3.47
Serotonin release as a possible mechanism of reserpine action. Science (1955) 3.03
3,4-Dihydroxyphenylalanine and 5-hydroxytryptophan as reserpine antagonists. Nature (1957) 2.67
The pharmacological properties of 2-methyl-2-n-propyl-1,3-propanediol dicarbamate (miltown), a new interneuronal blocking agent. J Pharmacol Exp Ther (1954) 2.55
Serotonin as a mediator of reserpine action in brain. J Pharmacol Exp Ther (1956) 2.26
[On the pharmacology of tofranil (N-(3-dimethylaminopropyl)-iminodibenzyl hydrochloride]. Arch Int Pharmacodyn Ther (1959) 2.17
Effect of iproniazid on serotonin metabolism in vivo. J Pharmacol Exp Ther (1957) 2.16
Evidence that serotonin has a role in brain function. Science (1955) 2.13
Assessment of drug effects on emotional behavior. Science (1956) 2.05
On the presence of 3-hydroxytyramine in brain. Science (1958) 2.03
Interaction of reserpine, serotonin, and lysergic acid diethylamide in brain. Science (1955) 1.99
Experimental induction of conflict-behaviour in cats: the effect of some anticholinergic compounds. Acta Pharmacol Toxicol (Copenh) (1955) 1.96
A neuropharmacological study on the effect of myanesin (tolserol) on motor systems. J Pharmacol Exp Ther (1949) 1.90
In vivo inhibition of liver and brain monoamine oxidase by 1-Isonicotinyl-2-isopropyl hydrazine. Proc Soc Exp Biol Med (1952) 1.86
Pharmacologic studies on a new central stimulant, alpha-(2-piperidyl) benzhydrol hydrochloride (MRD-108). J Pharmacol Exp Ther (1954) 1.83
Some central actions of 5-hydroxytryptamine and various antagonists. Br J Pharmacol Chemother (1956) 1.81
Factor I and gamma-aminobutyric acid. Nature (1956) 1.81
Metabolism of epinephrine containing isotopic carbon. III. J Biol Chem (1953) 1.74
Injections of bulbocapnine into the cerebral ventricles of cats. Br J Pharmacol Chemother (1955) 1.68
A 24-hour periodicity in the "LH-release apparatus" of female rats, disclosed by barbiturate sedation. Endocrinology (1950) 1.67
On the mechanism of drug potentiation by iproniazid (2-isopropyl-1-isonicotinyl hydrazine). J Pharmacol Exp Ther (1956) 1.61
Pharmacology of lysergic acid diethylamide and some of its related compounds. J Pharm Pharmacol (1957) 1.59
Pharmacologic and toxicologic observations on hydrazine derivatives of isonicotinic acid (rimifon, marsilid). Am Rev Tuberc (1952) 1.55
Studies on behavior. III. Effects of scopolamine on reversal of a discriminatory performance in pigeons. J Pharmacol Exp Ther (1957) 1.55
[Treatment of depressive states with an iminodibenzyl derivative (G 22355)]. Schweiz Med Wochenschr (1957) 1.53
Pharmacology of Rauwolfia alkaloids, including reserpine. Ann N Y Acad Sci (1954) 1.52
Effect of reserpine vasoconstriction caused by sympathomimetic amines. Lancet (1958) 1.51
The pharmacology of Rauwolfia. Pharmacol Rev (1956) 1.47
Amine oxidases. XI. Inhibition of monoamine oxidase by 1-isonicotinyl-2-isopropylhydrazine. J Biol Chem (1955) 1.47
Cholinergic and adrenergic components in the neurohumoral control of the release of LH in the rabbit. Endocrinology (1949) 1.46
The action of chlorpromazine on diencephalic sympathetic activity and on the release of adrenocorticotrophic hormone. Br J Pharmacol Chemother (1954) 1.41
Relationship of hallucinogens to adrenergic cerebral neurohumors. Science (1955) 1.40
The anti-emetic activity of 10-(gamma-dimethylaminopropyl)-2-chlorophenothiazine (chlorpromazine) in dog and cat. J Pharmacol Exp Ther (1954) 1.38
Comparison of some pharmacological properties of chlorpromazine, promethazine, and pethidine. Br J Pharmacol Chemother (1954) 1.36
Effect of drugs and metabolic alterations on brain stem arousal mechanism. J Pharmacol Exp Ther (1954) 1.33
The activity of some central depressant drugs in acute decorticate and diencephalic preparations. Arch Int Pharmacodyn Ther (1954) 1.33
A comparative study of the effects of drugs on the arousal system of the brain. Br J Pharmacol Chemother (1959) 1.32
Some indications of cerebral humoral mechanisms. Science (1953) 1.26
The effect of beta-diethylaminoethyl-diphenylpropylacetate hydrochloride (SKF No. 525-A) on hexobarbital. J Pharmacol Exp Ther (1954) 1.22
Effect of 2-methyl, 2-n-propyl-1,3-propanediol dicarbamate (Miltown) on central nervous system. Proc Soc Exp Biol Med (1954) 1.22
Differential action of anesthetics and interneuron depressants upon EEG arousal and recruitment responses. J Pharmacol Exp Ther (1956) 1.21
Characterization of central effects of serpasil (reserpin, a new alkaloid of Rauwolfia serpentina B.) and of their antagonistic reactions. Arch Int Pharmacodyn Ther (1954) 1.19
The depression of phospholipid turnover in brain tissue by chlorpromazine. J Neurochem (1956) 1.18
A facilitation action of reserpine on the central nervous system. Proc Soc Exp Biol Med (1954) 1.15
Significance of selected central mechanisms for the analysis of the action of reserpine. Ann N Y Acad Sci (1955) 1.14
Inhibition of hypothalamic, medullary and reflex vasomotor responses by chlorpromazine. Br J Pharmacol Chemother (1954) 1.13
Biological assessment of tranquillisers. I. J Pharm Pharmacol (1958) 1.12
Neuropharmacological aspects of reserpine. Ann N Y Acad Sci (1955) 1.11
The effect of benzilic acid diethylaminoethylester HCl (benactyzine) on stress-induced behaviour in the rat. Acta Pharmacol Toxicol (Copenh) (1955) 1.08
Disturbed chronic psychotic patients: pilot trial of stelazine. Br Med J (1958) 1.08
The action of mephenesin and other interneuron depressants on the brain stem. J Pharmacol Exp Ther (1954) 1.05
Chlorpromazine and narcotics in the management of pain of malignant lesions. J Am Med Assoc (1954) 1.05
A test for tranquillizing drugs. Arch Int Pharmacodyn Ther (1958) 1.05
Pharmacology of the psychotherapeutic drug benactyzine (beta-diethylaminoethyl benzilate hydrochloride). Proc Soc Exp Biol Med (1956) 1.03
The effect of alpha,beta-dihydrosy-gamma-(2 methylphenoxy) propane (myanesin, tolserol) on experimental spasticity in cats. J Pharmacol Exp Ther (1949) 1.03
New blocking agent against the development of LSD-25 psychosis. Science (1955) 1.03
Comparison of maximal seizures evoked by pentylenetetrazol (metrazol) and electroshock in mice, and their modification by anticonvulsants. J Pharmacol Exp Ther (1953) 1.02
Action of a series of benactyzine-derivatives and other compounds on stress-induced behavior in the rat. Acta Pharmacol Toxicol (Copenh) (1955) 1.00
A new hallucinogen: 3,4,5-trimethoxyphenyl-beta-aminopropane with notes on the stroboscopic phenomenon. J Ment Sci (1955) 0.99
A study of the anticonvulsant properties of phenobarbital and dilantin. Arch Int Pharmacodyn Ther (1954) 0.98
Drugs preventing motion sickness at sea. J Pharmacol Exp Ther (1954) 0.98
The pharmacology of beta-dimethylaminoethyl-2-methylbenzhydrylether hydrochloride (BS 5930). Arch Int Pharmacodyn Ther (1956) 0.98
Effects of chlorpromazine on the central nervous system of the cat: a possible neural basis for action. J Pharmacol Exp Ther (1956) 0.98
Effects of scopolamine and atropine electroencephalographic and behavioral reactions due to hypothalamic stimulation. J Pharmacol Exp Ther (1956) 0.97
Pharmacological properties of benzazoles. II. Sites of action in the central nervous system. J Pharmacol Exp Ther (1953) 0.97
Release of 5-hydroxytryptamine by benzoquinolizine derivatives with sedative action. Science (1957) 0.96
Reserpine antagonism of morphine analgesia in mice. Proc Soc Exp Biol Med (1954) 0.96
A new group of potent sedatives. J Pharmacol Exp Ther (1953) 0.96
Mechanism of blockade of pituitary activation in the rat by morphine, atropine and barbiturates. Endocrinology (1955) 0.96
Potentiating action of chlorpromazine and reserpine. Nature (1955) 0.95
Reserpine (serpasil) effects on epileptic monkeys. Proc Soc Exp Biol Med (1955) 0.93
Persistence of reserpine action after the disappearance of drug from brain: effect on serotonin. J Pharmacol Exp Ther (1956) 0.92
Further characterization of central effects of reserpine (serpasil). Am J Physiol (1955) 0.92
Motion sickness. Pharmacol Rev (1955) 0.92
Antagonism studies on reserpine and certain CNS depressants. Proc Soc Exp Biol Med (1954) 0.90
Effect of tranquilizing drugs on fighting response of Siamese fighting fish. Science (1956) 0.90
Potentiating effect of iproniazid on action of some sympathicomimetic amines. Proc Soc Exp Biol Med (1954) 0.90
Prophylactic and therapeutic control of vestibular disturbances with dimenhydrinate. J Am Med Assoc (1951) 0.90
Action of nicotine and of the "ganglioplegiques centraux" on the electrical activity of the brain. J Pharmacol Exp Ther (1954) 0.87
Inhibitory actions of chlorpormazine on motor activity. Arch Int Pharmacodyn Ther (1955) 0.87
Comparative effects of various Rauwolfia alkaloids on centrally evoked vasopressor responses. J Pharmacol Exp Ther (1957) 0.86
A stereotyped response induced by mescaline in mice as a means of investigating the properties of drugs acting on the CNS. J Pharm Pharmacol (1958) 0.86
Chlorpromazine. I. The action of chlorpromazine and related phenothiazines on the EEG and its activation. J Pharmacol Exp Ther (1958) 0.86
[Comparative action of products, numbers 3277 R.P., 4560 R.P., 4909 R.P. and of phenobarbital on convulsions induced by strychnine, picrotoxin, cocaine, cafeine and amphetamine]. C R Seances Soc Biol Fil (1956) 0.86
Blockade of the release of pituitary ovulating hormone in the rat by chlorpromazine and reserpine: possible mechanisms of action. Endocrinology (1957) 0.86
Modifications of the pharmacology of reserpine and serotonin by iproniazid. J Pharmacol Exp Ther (1957) 0.86
[Activity of a new phenothiazine in psychiatry and neurology; therapeutic properties of 10-(3-dimethylamino-2-methyl-propyl)-3-methoxyphenothiazine]. Presse Med (1956) 0.85
Effects of mescaline in laboratory animals and influence of ataraxics on mescaline-response. Proc Soc Exp Biol Med (1956) 0.85
The antiemetic activity of alkaloids of Rauwolfia serpentina. J Pharmacol Exp Ther (1956) 0.85
Alterations in somatic afferent transmission through the thalamus by central mechanisms and barbiturates. J Pharmacol Exp Ther (1957) 0.84
Frenquel corrects certain cerebral electrographic changes. Science (1955) 0.84
The pharmacological properties of alpha:beta-dihydroxy-gamma-(2-methylphenoxy)-propane (myanesin). Br J Pharmacol Chemother (1946) 0.83
Experimental induction of conflict-behaviour in cats: the effect of some anticholinergic compounds. Acta Pharmacol Toxicol (Copenh) (1955) 1.96
The metabolism of ethyl alcohol. Pharmacol Rev (1952) 1.38
The metabolism of ethyl alcohol. Nature (1952) 1.28
The autonomic reaction of psycho-neurotics to a new sedative: benactyzine NFN, suavitil (R) (benzilic acid diethylaminoethylester hydrochloride). Acta Psychiatr Neurol Scand (1955) 1.22
A drug sensitizing the organism to ethyl alcohol. Lancet (1948) 1.18
Investigations into autonomic responses during emotion. Acta Psychiatr Neurol Scand (1955) 1.13
[Suavitil, a new compound with specific effect on the central nervous system]. Ugeskr Laeger (1955) 1.13
The effect of benzilic acid diethylaminoethylester HCl (benactyzine) on stress-induced behaviour in the rat. Acta Pharmacol Toxicol (Copenh) (1955) 1.08
The antabuse effect of some compounds related to antabuse and cyanamide. Acta Pharmacol Toxicol (Copenh) (1952) 1.02
Treatment of alcoholism with tetraethylthiuram disulfide (antabuse). J Am Med Assoc (1949) 0.97
The clinical pharmacology of the hallucinogens. Clin Pharmacol Ther (1963) 0.87
The pharmacological classification of central nervous depressants. J Pharm Pharmacol (1958) 0.81
The rate of acetaldehyde metabolism in isolated livers and hind limbs of rabbits treated with antabuse (tetraethylthiuramdisulphide). Acta Pharmacol Toxicol (Copenh) (1949) 0.80
[A pharmacologist looks at psychopharmacological tests]. Nord Psykiatr Tidsskr (1962) 0.79
Audiogenic abnormality spectra, twenty-four hour periodicity, and lighting. Science (1958) 0.79
The effect of benactyzine on the conditioned responses in the rat. Acta Pharmacol Toxicol (Copenh) (1956) 0.78
Formation of acetaldehyde in the organism in relation to dosage of antabuse (tetraethylthiuramdisulphide) and to alcohol-concentration in blood. Acta Pharmacol Toxicol (Copenh) (1949) 0.76
The effect of benactyzine on the electroencephalogram in man. Acta Pharmacol Toxicol (Copenh) (1957) 0.75
Experimental induction of conflict-behaviour in cats: its use in pharmacological investigations. Acta Pharmacol Toxicol (Copenh) (1955) 0.75
Deaths of alcoholic patients treated with disulfiram (tetraethylthiuram disulfide) in Denmark. Q J Stud Alcohol (1952) 0.75
The antagonism between alcohol and acetaldehyde in rabbits. Acta Pharmacol Toxicol (Copenh) (1952) 0.75
[Alcoholism and its treatment. Pathogenesis and development of alcoholism]. Dtsch Med Wochenschr (1962) 0.75
Site of the formation of acetaldehyde after ingestion of antabuse (tetraethylthiuramdisulphide) and alcohol. Acta Pharmacol Toxicol (Copenh) (1949) 0.75
Experiences with the bioassay of digitalis on guinea pigs. Acta Pharmacol Toxicol (Copenh) (1951) 0.75
[The pneumoencephalogram in the concentration camp syndrome]. Ugeskr Laeger (1955) 0.75
[Theory and therapy of neuroses]. Ugeskr Laeger (1956) 0.75
[Methemoglobinemia following administration of phenacetin and acet-4-chloranilide]. Ugeskr Laeger (1950) 0.75
[Medical therapy of alcoholism]. Dia Med (1953) 0.75
Is acetaldehyde an intermediary product in normal metabolism? Biochim Biophys Acta (1950) 0.75
[Results and experiences with Millin's technic of prostatectomy; 100 cases]. Z Urol (1957) 0.75
[Pentymal test in organic intellectual reduction]. Ugeskr Laeger (1962) 0.75
Benactyzine. Antibiotic Med Clin Ther (New York) (1958) 0.75
Determination of 2-methyl-2,4-pentane diol (hexylene glycol) in the urine of man and rats. Acta Pharmacol Toxicol (Copenh) (1958) 0.75
On the diagnosis of neurosis. Acta Psychiatr Scand Suppl (1959) 0.75
Biochemical methods in the treatment of alcoholism, with special reference to antabuse. Proc R Soc Med (1950) 0.75
The classification of psychotropic drugs. J Neuropsychiatr (1963) 0.75
[A primary sarcoma of the gallbladder]. Zentralbl Chir (1954) 0.75
[Not Available]. Manedsskr Prakt Laegegern (1959) 0.75
[Choral & mechloral]. Ugeskr Laeger (1958) 0.75
[Antabus therapy of alcoholism]. Dtsch Med Wochenschr (1950) 0.75
[Nocturnal leg; a negative therapeutic experiment]. Ugeskr Laeger (1952) 0.75
[Neurosis theory and therapy]. Ugeskr Laeger (1955) 0.75
The influence of benactyzine on reaction-time. Acta Pharmacol Toxicol (Copenh) (1957) 0.75
[Correlation between the pharmacodynamic properties of psychopharmaca and their clinical action]. Nord Med (1962) 0.75
Drinking habits and motor driving; an analysis of 207 offenders. Acta Med Leg Soc (Liege) (1956) 0.75
[Weber-Christian disease]. Ugeskr Laeger (1953) 0.75
[Not Available]. Med Forum (1949) 0.75
[Studies on seasick seamen]. Ugeskr Laeger (1953) 0.75
The excretion of hexylene glycol (2-methyl-2,4-pentane diol) in man. Acta Pharmacol Toxicol (Copenh) (1958) 0.75
[Not Available]. Arch Mal Prof (1949) 0.75